In compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (‘Listing Regulations’), Rossari Biotech has informed that the Board of Directors of the Company at its meeting held on July 30, 2021 has resolved to make a strategic investment by acquiring and/or subscribing to equity shares equivalent to 50.10% of the issued and paid-up share capital of Romakk Chemicals (‘Romakk’) and accordingly, enter into a Share Subscription Share Purchase and Shareholders Agreement to regulate the rights and obligations of the shareholders of Romakk inter-se and for the internal management. The disclosures pertaining to this acquisition, pursuant to provisions of Regulation 30 (2) read with Para A of Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), is annexed as ‘Annexure A’ to this outcome. The aforesaid information will also be available on Company’s website at www.rossari.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 3651.95 |
| Tata Chemicals | 804.85 |
| SRF | 2551.40 |
| Pidilite Inds. | 1364.45 |
| Deepak Nitrite | 1751.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: